← Back to Search

Dietary Supplement

Alpha Hope for Cognitive Impairment

N/A
Waitlist Available
Led By Richard Bloomer, PhD
Research Sponsored by University of Memphis
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Healthy (no diagnosed disease, including but not limited to metabolic, cardiovascular disease, or neurological disease)
Able to consume calcium carbonate (the placebo)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 week timepoint
Awards & highlights

Study Summary

The purpose of the present research study is to evaluate the claims about the supplement influencing cognitive function that may impact performance on cognitive task and related biochemical measures. The synergistic administration of Pyrroloquinoline Quinone and molecular Hydrogen (in the form of Alpha Hope) will be evaluated in adults without a diagnosis of disease (i.e., otherwise healthy adults-the population the supplement is marketed to) on certain biochemical markers, subject's self-assessed wellness, and functional measurements determined via computer tests.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 week timepoint
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 week timepoint for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
AX-Continuous Performance Test
Blood Pressure
Trigger Finger Disorder
+6 more

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Alpha HopeExperimental Treatment1 Intervention
Each tablet contains 10 mg PQQ and 40 mg (19% DV) magnesium as well as malic acid, dextrose, adipic acid, citric acid, natural flavor, and blackberry leaf extract
Group II: PlaceboPlacebo Group1 Intervention
Same formulation as experimental with 250 mg calcium carbonate replacing the magnesium and PQQ.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Drink
2022
N/A
~100

Find a Location

Who is running the clinical trial?

University of MemphisLead Sponsor
70 Previous Clinical Trials
11,875 Total Patients Enrolled
Calerie LLCUNKNOWN
Richard Bloomer, PhDPrincipal InvestigatorUniversity of Memphis
16 Previous Clinical Trials
475 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Effect of Alpha Hope Dietary Supplement on Health and Cognitive Performance
Richard Bloomer 2022. "Effect of Alpha Hope Dietary Supplement on Health and Cognitive Performance". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05589051.
~5 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top